NEOPLASMS, HEAD AND NECK
Clinical trials for NEOPLASMS, HEAD AND NECK explained in plain language.
Never miss a new study
Get alerted when new NEOPLASMS, HEAD AND NECK trials appear
Sign up with your email to follow new studies for NEOPLASMS, HEAD AND NECK, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
New immunotherapy cocktail aims to shrink head and neck tumors
Disease control OngoingThis study tests whether combining different immunotherapies works better than one alone for people with a type of head and neck cancer that has come back or spread. The trial includes 316 adults whose tumors have a specific marker (PD-L1 positive) and who have not had prior trea…
Matched conditions: NEOPLASMS, HEAD AND NECK
Phase: PHASE2 • Sponsor: GlaxoSmithKline • Aim: Disease control
Last updated May 17, 2026 10:08 UTC
-
New combo therapy aims to boost survival in hard-to-treat head and neck cancer
Disease control OngoingThis phase 3 study tests whether adding an experimental immunotherapy (PDS0101) to standard pembrolizumab helps people with advanced HPV16-positive head and neck cancer live longer or delay tumor growth. About 252 adults whose cancer has spread or returned and cannot be removed b…
Matched conditions: NEOPLASMS, HEAD AND NECK
Phase: PHASE3 • Sponsor: PDS Biotechnology Corp. • Aim: Disease control
Last updated May 13, 2026 15:58 UTC